By outsourcing high-end processes that demand advanced analytical and technical skills, biopharm companies are reaping substantial savings.
Hazel Aranha
Advertisement
Articles by Hazel Aranha
The biotechnology and pharmaceutical industries have some overriding concerns, namely regulatory and compliance issues, insufficient manufacturing capacity, and the economic challenges of producing niche drugs and therapies.
Advertisement
Latest Updated Articles
Outsourcing: Transition from Business Process Outsourcing to Knowledge Process OutsourcingPublished: May 1st 2007 | Updated:
Disposable Processing Gains You a Competitive Edge: Enhancing Manufacturing Capacity with Disposable Filters, Connectors, and Membrane ChromatographyPublished: October 1st 2003 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
